Asymmetric dimethylarginine (ADMA) levels display a morning peak in patients with acute myocardial infarction

Disease Markers

Volumn 30, Issue 5, 2011, Pages 245-252

  Bergheanu, Sandrin C ^a   Van Der Laarse, Arnoud ^a   Van Der Bom, Johanna G ^a   Van Der Hoeven, Bas L ^a   Le Cessie, Saskia ^a   De Jong, Margreet G ^a   Liem, Su San ^a   Schalij, Martin J ^a   Jukema, J Wouter ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Asymmetric dimethylarginine; circadian rhythm; myocardial infarction; platelets; thrombosis

Indexed keywords

N(G),N(G) DIMETHYLARGININE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIAC PATIENT; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDY; EMERGENCY CARE; FEMALE; HEART CATHETERIZATION; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REST; SYMPTOM;

EID: 79960723739     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0781     Document Type: Article

References (46)

1. C.P. Cannon, C.H. McCabe, P.H. Stone et al., Circadian variation in the onset of unstable angina and non-Q-wave acute myocardial infarction (the TIMI III Registry and TIMI IIIB), Am J Cardiol 79 (1997), 253-258. (Pubitemid 27100620)
2. M.C. Cohen, K.M. Rohtla, C.E. Lavery et al., Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death, Am J Cardiol 79 (1997), 1512-1516. (Pubitemid 27251072)
3. J.R. Leiza, J.M. de Llano, J.B. Messa et al., New insights into the circadian rhythm of acute myocardial infarction in subgroups, Chronobiol Int 24 (2007), 129-141. (Pubitemid 46280002)
4. J.R. Marler, T.R. Price, G.L. Clark et al., Morning increase in onset of ischemic stroke, Stroke 20 (1989), 473-506.
5. J.E. Muller, P.H. Stone, Z.G. Turi et al., Circadian variation in the frequency of onset of acute myocardial infarction, N Engl J Med 313 (1985), 1315-1322. (Pubitemid 16206020)
6. M.W. Millar-Craig, C.N. Bishop et al., Circadian variation of blood-pressure, Lancet 1 (1978), 795-797.
7. A.M. Ehrly and G. Jung, Circadian rhythm of human blood viscosity, Biorheology 10 (1973), 577-583.
8. G.H. Tofler, D. Brezinski, A.I. Schafer et al., Concurrent morning increase in platelet aggregability and the risk of myocar-dial infarction and sudden cardiac death, N Engl J Med 316 (1987), 1514-1518. (Pubitemid 17076236)
9. D.A. Brezinski, G.H. Tofler, J.E. Muller et al., Morning increase in platelet aggregability. Association with assumption of the upright posture, Circulation 78 (1988), 35-40.
10. M. Fujita and D. Franklin, Diurnal changes in coronary blood flow in conscious dogs, Circulation 76 (1987), 488-491. (Pubitemid 17124752)
11. J.E. Muller, G.H. Tofler and P.H. Stone, Circadian variation and triggers of onset of acute cardiovascular disease, Circulation 79 (1989), 733-743. (Pubitemid 19100532)
12. P. Vallance, A. Leone, A. Calver et al., Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure, Lancet 339 (1992), 572-575.
13. P. Vallance and J. Leiper, Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohy-drolase pathway, Arterioscler Thromb Vasc Biol 24 (2004), 1023-1030. (Pubitemid 38737826)
14. L.R. de Meirelles, A.C. Mendes-Ribeiro, M.M. Santoro et al., Inhibitory effects of endogenous L-arginine analogues on nitric oxide synthesis in platelets: role in platelet hyperaggrega-bility in hypertension, Clin Exp Pharmacol Physiol 34 (2007), 1267-1271. (Pubitemid 350013236)
15. M. Juonala, J.S. Viikari, G. Alfthan et al., Brachial artery flow-mediated dilation and asymmetrical dimethylarginine in the cardiovascular risk in young Finns study, Circulation 116 (2007), 1367-1373. (Pubitemid 47417562)
16. J. Loscalzo, Nitric oxide insufficiency, platelet activation, and arterial thrombosis, Circ Res 88 (2001), 756-762. (Pubitemid 32429970)
17. J.E. Freedman, J. Loscalzo, M.R. Barnard et al., Nitric oxide released from activated platelets inhibits platelet recruitment, J Clin Invest 100 (1997), 350-356. (Pubitemid 27349081)
18. V. Achan, M. Broadhead, M. Malaki et al., Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase, Arterioscler Thromb Vasc Biol 23 (2003), 1455-1459. (Pubitemid 36994536)
19. J.T. Kielstein, B. Impraim, S. Simmel et al., Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans, Circulation 109 (2004), 172-177. (Pubitemid 38114135)
20. R.H. Boger, S.M. Bode-Boger, P.S. Tsao et al., An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes, J Am Coll Cardiol 36 (2000), 2287-2295.
21. B.L. van der Hoeven, S.S. Liem, J.W. Jukema et al., Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angio-graphic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study, J Am Coll Cardiol 51 (2008), 618-626. (Pubitemid 351186867)
22. B.L. van der Hoeven, S.S. Liem, J. Dijkstra et al., Stent malap-position after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! Intervention Study, J Am Coll Cardiol Intv 1 (2008), 192-201. (Pubitemid 351506561)
23. F. Schulze, R. Wesemann, E. Schwedhelm et al., Determination of ADMA using a novel ELISA assay, Clin Chem Lab Med 42 (2004), 1377-1383.
24. G.W. Oehlert, A note on the delta method. American Statistician 46 27-29.
25. J.E. Freedman, B. Ting, B. Hankin et al., Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes, Circulation 98 (1998), 1481-1486. (Pubitemid 28481663)
26. A. Fujimura, K. Ohashi and A. Ebihara, Daily variations in platelet aggregation and adhesion in healthy subjects, Life Sci 50 (1992), 1043-1047.
27. E. Haus, M. Cusulos and L. Sackett-Lundeen, Circadian variations in blood coagulation parameters, alpha-antitrypsin antigen and platelet aggregation and retention in clinically healthy subjects, Chronobiol Int 7 (1990), 203-216. (Pubitemid 20357229)
28. L. Undar, C. Turkay and L. Korkmaz, Circadian variation in circulating platelet aggregates, Ann Med 21 (1989), 429-433. (Pubitemid 20029328)
29. E. Haus, Chronobiology of hemostasis and inferences for the chronotherapy of coagulation disorders and thrombosis prevention, Adv Drug Deliv Rev 59 (2007), 966-984. (Pubitemid 47534218)
30. D. Fliser, Asymmetric dimethylarginine (ADMA): the silent transition from an 'uraemic toxin' to a global cardiovascular risk molecule, Eur J Clin Invest 35 (2005), 71-79. (Pubitemid 40222806)
31. D. Ardigo, M. Stüehlinger, L. Franzini et al., ADMA is independently related to flow-mediated vasodilation in subjects at low cardiovascular risk, Eur J Clin Invest 37 (2007), 263-269. (Pubitemid 46439414)
32. J. Wang, A.S. Sim, X.L. Wang et al., Relations between markers of renal function, coronary risk factors and the occurrence and severity of coronary artery disease, Atherosclerosis 197 (2008), 853-859. (Pubitemid 351417885)
33. E.L. Kanabrocki, R.B. Sothern, L. Sackett-Lundeen et al., Creatinine clearance and blood pressure: a 34-year circadian study, Clin Ter 159 (2008), 409-417.
34. E. Haus, Annual Review of Chronopharmacology 4 (1988), 333-424.
35. S. Clarke, Protein methylation, Curr Opin Cell Biol 5 (1993), 977-983. (Pubitemid 23340504)
36. A.E. McBride and P.A. Silver, State of the arg: protein methy-lation at arginine comes of age, Cell 106 (2001), 5-8. (Pubitemid 32709951)
37. R.H. Boger, K. Sydow, J. Borlak et al., LDL cholesterol up-regulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases, Circ Res 87 (2000), 99-105. (Pubitemid 30616904)
38. R.J. Nijveldt, T. Teerlink, M.P. Siroen et al., The liver is an important organ in the metabolism of asymmetrical dimethy-larginine (ADMA), Clin Nutr 22 (2003), 17-22. (Pubitemid 36193176)
39. J. Murray-Rust, J. Leiper, M. McAlister et al., Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase, Nat Struct Biol 8 (2001), 679-683. (Pubitemid 32757926)
40. H. Dayoub, V. Achan, S. Adimoolam et al., Dimethylargi-nine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence, Circulation 108 (2003), 3042-3047. (Pubitemid 37553576)
41. A. Ito, P.S. Tsao, S. Adimoolam et al., Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase, Circulation 99 (1999), 3092-3095. (Pubitemid 29289071)
42. T. Tamaru, J. Hirayama, Y. Isojima et al., CK2alpha phospho-rylates BMAL1 to regulate the mammalian clock, Nat Struct Mol Biol 16 (2009), 446-448.
43. P. Angleton, W.L. Chandler and G. Schmer, Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1), Circulation 79 (1989), 101-106. (Pubitemid 19043680)
44. J.G. van der Bom, M.L. Bots, F. Haverkate, C. Kluft et al., The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1, Blood 101 (2003), 1841-1844. (Pubitemid 36237582)
45. S.C. Bergheanu, D. Pons, J.W. Jukema et al., Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of Plasminogen Activator Inhibitor-1, Chronobiol Int 26 (2009), 637-652.
46. A. Tanaka, T. Kawarabayashi, D. Fukuda et al., Circadian variation of plaque rupture in acute myocardial infarction, Am J Cardiol 93 (2004), 1-5. (Pubitemid 38022024)